Introduction to Soralieva 200mg Tablet

Soralieva 200mg Tablet belongs to the class of cancer medications known as multikinase inhibitors containing the active ingredient sorafenib. Soralieva 200mg Tablet is a medication primarily used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and thyroid cancer.  

It is not recommended to take Soralieva 200mg Tablet if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience skin rashes, heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. It is not recommended for use in children and adolescents.  Patients with diabetes should have their blood sugar levels examined frequently to see whether the dosage of anti-diabetic medications needs to be changed to reduce the risk of low blood sugar. Your doctor will monitor liver function tests, fluid and electrolyte balance to help identify and manage potential side effects promptly.

It is not advised to use this medication while pregnant since it may harm the fetus Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because this medication might affect your baby's growth and development. This treatment may affect the fertility in both men and women, it is advised to consult your doctor before starting the therapy.

It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.

Uses of Soralieva 200mg Tablet

• Advanced renal cell carcinoma
• Advanced hepatocellular carcinoma
• Differentiated  thyroid carcinoma

Therapeutic Effects of Soralieva 200mg Tablet

Soralieva 200mg Tablet works by inhibiting multiple protein kinases involved in tumor cell proliferation and angiogenesis (the formation of new blood vessels that supply tumors). Specifically, it targets receptors for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and Raf kinases, which play key roles in cancer development and progression.  This stops the growth and spread of the tumor cells to other organs, as well the formation of blood vessels in the tumor cells.

Interaction of Soralieva 200mg Tablet with other drugs

Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Soralieva 200mg Tablet and reduce effectiveness by causing undesirable side effects.

More Information about Soralieva 200mg Tablet

• Store Soralieva 200mg Tablet Tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children

How to consume Soralieva 200mg Tablet

The medicine will be prescribed to you by a healthcare professional in a hospital setting. It is not recommended to take this medication with meals that are high in fat since this may reduce Soralieva 200mg Tablet's effectiveness. Take the pills at least one hour before or two hours after a high-fat meal if you plan to eat one. The dose will be decided by your healthcare professional based on your conditions.  Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Soralieva 200mg Tablet tablet at the same time every day.